p90RSK pathway inhibition synergizes with cisplatin in TMEM16A overexpressing head and neck cancer. Yassin-Kassab A, Chatterjee S, Khan N, Wang N, et al. BMC Cancer 2024;24:233.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yassin-Kassab A, Chatterjee S, Khan N, Wang N, et al. p90RSK pathway inhibition synergizes with cisplatin in TMEM16A overexpressing head and neck cancer. BMC Cancer 2024;24:233.
PMID: 38373988